Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Fauci: J&J vaccination could resume shortly

By Brian Buntz | April 19, 2021

Johnson & JohnsonThe third vaccine to win emergency use authorization in the U.S. could reappear after a 10-day pause, according to Dr. Anthony Fauci, the nation’s top disease expert.

FDA and CDC had recommended temporarily suspending the use of the Johnson & Johnson (NYSE:JNJ) vaccine after six women developed serious blood clots within weeks of vaccination.

Fauci stressed that he was uncertain how CDC and FDA might proceed with the vaccine but believed that it was unlikely the pause would become permanent.

The vaccine will likely be accompanied by a warning mentioning a small risk of blood clotting problems, including cerebral venous sinus thrombosis presenting with low platelet count.

“I do think that there will likely be some sort of warning or restriction or risk assessment. I don’t think it’s just going to go back and say, ‘OK, everything’s fine,’ and go right back,” Fauci said in an interview with NBC’s “Meet the Press.”

A CDC advisory panel is set to discuss the J&J vaccine on April 23. The committee also met on April 13 to examine the blood-clot risk potentially associated with the vaccine.

Another justification for the temporary pause on using the J&J vaccine is for the CDC and FDA to enable the agencies to formulate guidance for medical professionals. “You want to let the physicians out there who see women or anybody with this condition [know] that the standard way that you would think about treating blood clots is with the anticoagulant heparin,” Fauci said. “That would be contraindicated in this case because heparin could actually make things worse.”

Tell Us What You Think! Cancel reply

Related Articles Read More >

Pfizer logo
Pfizer CEO tests positive for COVID-19
Pfizer logo
Pfizer and BioNTech seek EMA authorization for COVID-19 vaccination in young children
Pfizer logo
FDA allows pharmacists to prescribe Paxlovid 
vaccine
Will COVID-19 vaccines be updated by fall? 

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards